Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Beginning Cash 2 year CAGR for the Trailing 12 Months (TTM) ending December 31, 2023: -14.33%

Alpha Tau Medical Ltd Beginning Cash 2 year CAGR is -14.33% for the Trailing 12 Months (TTM) ending December 31, 2023, a -105.51% change year over year. Beginning Cash is the amount of cash held by a company at the beginning of a specific period. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Alpha Tau Medical Ltd Beginning Cash for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 5.96 M, a -75.00% change year over year.
Alpha Tau Medical Ltd Beginning Cash for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 23.85 M, a 47.48% change year over year.
Alpha Tau Medical Ltd Beginning Cash for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 16.17 M, a 3,414.18% change year over year.
Alpha Tau Medical Ltd Beginning Cash for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 460.25 K, a -86.47% change year over year.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends